Dai-ichi Life
59
19M
44
0.48
2
0.24
2
- Areas of investment
Summary
Dai-ichi Life is the famous Corporate Investor, which was founded in 1902. The company was established in Asia in Japan. The leading representative office of defined Corporate Investor is situated in the Tokyo.
The top activity for fund was in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually.
The fund has exact preference in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Neurotrack, CureApp, Meltin MMI. For fund there is a match between the location of its establishment and the land of its numerous investments - Japan. Among the most successful fund investment fields, there are Robotics, Information Technology. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Dai-ichi Life, startups are often financed by Real Tech Fund, Rohto Pharmaceutical, ANA Holdings. The meaningful sponsors for the fund in investment in the same round are SBI Investment, Rohto Pharmaceutical, Sompo Holdings. In the next rounds fund is usually obtained by Rohto Pharmaceutical, Mirai Creation Fund, Meiji Yasuda Life Insurance Co..
Investments analytics
Analytics
- Total investments
- 59
- Lead investments
- 2
- Exits
- 2
- Rounds per year
- 0.48
- Follow on index
- 0.24
- Investments by industry
- Health Care (15)
- Biotechnology (11)
- Financial Services (8)
- Medical (8)
- Task Management (6) Show 86 more
- Investments by region
-
- Japan (54)
- United States (2)
- United Kingdom (1)
- Tanzania (1)
- Peak activity year
- 2018
- Number of Unicorns
- 1
- Number of Decacorns
- 1
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Avg. valuation at time of investment
- 43M
- Group Appearance index
- 0.95
- Avg. company exit year
- 13
- Strategy success index
- 0.20
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| CureApp | 27 Feb 2018 | Health Care, Medical | Early Stage Venture | 13M | Chiyoda, Japan |
| GITAI | 24 May 2023 | Artificial Intelligence, Robotics, Virtual Reality, Virtualization, Virtual World, Space Travel | Early Stage Venture | 36M | Chiyoda, Japan |
| Red Clay | 26 Aug 2014 | Software, Product Design, Collaborative Consumption | Seed | 1M | United States, California, San Francisco |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.